Estabrook Capital Management’s GSK GSK Stock Holding History

Estabrook Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.6K	Hold	1,443	–	–	0.01%	164
2025 Q4	$70.8K	Hold	1,443	–	–	0.01%	170
2025 Q3	$62.3K	Hold	1,443	–	–	0.01%	177
2025 Q2	$55.4K	Hold	1,443	–	–	0.01%	177
2025 Q1	$55.9K	Hold	1,443	–	–	0.01%	179
2024 Q4	$48.8K	Hold	1,443	–	–	0.01%	191
2024 Q3	$59K	Hold	1,443	–	–	0.01%	193
2024 Q2	$55.6K	Hold	1,443	–	–	0.01%	191
2024 Q1	$61.9K	Hold	1,443	–	–	0.01%	190
2023 Q4	$53.5K	Hold	1,443	–	–	0.01%	200
2023 Q3	$52.3K	Hold	1,443	–	–	0.01%	194
2023 Q2	$51.4K	Hold	1,443	–	–	0.01%	203
2023 Q1	$51.3K	Hold	1,443	–	–	0.01%	211
2022 Q4	$50.7K	Hold	1,443	–	–	0.01%	209
2022 Q3	$42.5K	Sell	1,443 -1	-0.1%	-$38	0.01%	214
2022 Q2	$78.6K	Hold	1,444	–	–	0.01%	185
2022 Q1	$78.6K	Hold	1,444	–	–	0.01%	193
2021 Q4	$79.6K	Buy	1,444 +118	+9%	+$6.14K	0.01%	197
2021 Q3	$63.4K	Hold	1,326	–	–	0.01%	181
2021 Q2	$66K	Hold	1,326	–	–	0.01%	187
2021 Q1	$59.2K	Sell	1,326 -720	-35%	-$32.7K	0.01%	193
2020 Q4	$94.1K	Hold	2,046	–	–	0.02%	164
2020 Q3	$96.3K	Hold	2,046	–	–	0.02%	152
2020 Q2	$104K	Hold	2,046	–	–	0.02%	152
2020 Q1	$96.9K	Hold	2,046	–	–	0.02%	150
2019 Q4	$120K	Hold	2,046	–	–	0.02%	160
2019 Q3	$109K	Sell	2,046 -120	-6%	-$6.17K	0.02%	159
2019 Q2	$108K	Hold	2,166	–	–	0.02%	159
2019 Q1	$113K	Hold	2,166	–	–	0.02%	156
2018 Q4	$103K	Hold	2,166	–	–	0.02%	152
2018 Q3	$109K	Hold	2,166	–	–	0.02%	161
2018 Q2	$109K	Hold	2,166	–	–	0.02%	160
2018 Q1	$106K	Hold	2,166	–	–	0.02%	166
2017 Q4	$96.1K	Sell	2,166 -320	-13%	-$14.8K	0.01%	181
2017 Q3	$126K	Hold	2,486	–	–	0.02%	167
2017 Q2	$134K	Hold	2,486	–	–	0.02%	164
2017 Q1	$131K	Sell	2,486 -800	-24%	-$40.6K	0.02%	164
2016 Q4	$158K	Hold	3,286	–	–	0.02%	154
2016 Q3	$177K	Hold	3,286	–	–	0.03%	144
2016 Q2	$178K	Hold	3,286	–	–	0.03%	140
2016 Q1	$167K	Hold	3,286	–	–	0.02%	141
2015 Q4	$166K	Sell	3,286 -896	-21%	-$45.7K	0.02%	146
2015 Q3	$201K	Sell	4,182 -120	-3%	-$6.25K	0.03%	143
2015 Q2	$224K	Sell	4,302 -160	-4%	-$9.01K	0.03%	147
2015 Q1	$257K	Sell	4,462 -1,567	-26%	-$89.8K	0.03%	145
2014 Q4	$322K	Sell	6,029 -540	-8%	-$30.2K	0.04%	134
2014 Q3	$377K	Sell	6,569 -88,938	-93%	-$5.45M	0.04%	129
2014 Q2	$6.38M	Sell	95,507 -37,392	-28%	-$2.53M	0.66%	42
2014 Q1	$8.88M	Sell	132,899 -7,339	-5%	-$496K	0.9%	38
2013 Q4	$9.36M	Sell	140,238 -3,528	-2%	-$229K	0.96%	37
2013 Q3	$9.02M	Sell	143,766 -13,283	-8%	-$855K	0.98%	37
2013 Q2	$9.81M	Buy	+157,049	New	+$9.97M	1.04%	36

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Estabrook Capital Management's GSK Position: Q1 2026 in Review

Estabrook Capital Management held its GSK (GSK) position steady in Q1 2026 at 1,443 shares worth $79.6K. The position accounts for 0.01% of the portfolio, ranked #164.

Estabrook Capital Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.81M in Q2 2013. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Estabrook Capital Management held 1,443 shares of GSK worth $79.6K as of Q1 2026.
Estabrook Capital Management left its GSK share count unchanged in Q1 2026.
GSK made up 0.01% of Estabrook Capital Management's portfolio in Q1 2026, its #164 holding.
Estabrook Capital Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
Estabrook Capital Management's GSK position peaked at $9.81M in Q2 2013.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.